{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:55:30Z","timestamp":1786650930338,"version":"build-2736575974"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Asian J Androl"],"published-print":{"date-parts":[[2014]]},"DOI":"10.4103\/1008-682x.122868","type":"journal-article","created":{"date-parts":[[2014,4,30]],"date-time":"2014-04-30T07:53:01Z","timestamp":1398844381000},"page":"413","source":"Crossref","is-referenced-by-count":2,"title":["Long-term survival of participants in the prostate cancer prevention trial"],"prefix":"10.4103","volume":"16","author":[{"given":"Oliver","family":"Sartor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JonathanL","family":"Silberstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1008-682X.122868-1","first-page":"2239","volume-title":"Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter","author":"Thompson","year":"2004","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1008-682X.122868-2","first-page":"234","volume-title":"Prostate Cancer Prevention Trial, Urologic Diseases in America Project Finasteride reduces the risk of incident clinical benign prostatic hyperplasia","author":"Parsons","year":"2012","journal-title":"Eur Urol"},{"key":"key-10.4103\/1008-682X.122868-3","first-page":"1128","volume-title":"Effect of finasteride on the sensitivity of PSA for detecting prostate cancer","author":"Thompson","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"key-10.4103\/1008-682X.122868-4","first-page":"1749","volume-title":"Finasteride improves the sensitivity of digital rectal examination for prostate cancer detection","author":"Thompson","year":"2007","journal-title":"J Urol"},{"key":"key-10.4103\/1008-682X.122868-5","first-page":"2996","volume-title":"Erectile dysfunction and subsequent cardiovascular disease","author":"Thompson","year":"2005","journal-title":"JAMA"},{"key":"key-10.4103\/1008-682X.122868-6","first-page":"215","volume-title":"The influence of finasteride on the development of prostate cancer","author":"Thompson","year":"2003","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1008-682X.122868-7","first-page":"603","volume-title":"Long-term survival of participants in the prostate cancer prevention trial","author":"Thompson","year":"2013","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1008-682X.122868-8","unstructured":"Available from: http:\/\/www.uspreventiveservicestaskforce.org\/prostatecancerscreening\/prostatefinalrs.htm [Last accessed on 2013 Sep 21]."},{"key":"key-10.4103\/1008-682X.122868-9","unstructured":"Available from: http:\/\/www.fda.gov\/drugs\/drugsafety\/ucm258314.htm [Last accessed on 2013 Sep 21]."},{"key":"key-10.4103\/1008-682X.122868-10","first-page":"1192","volume-title":", REDUCE Study Group.Effect of dutasteride on the risk of prostate cancer","author":"Andriole","year":"2010","journal-title":"N Engl J Med"}],"container-title":["Asian Journal of Andrology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:24:41Z","timestamp":1786649081000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1008-682X.122868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"alternative-id":["122868"],"URL":"https:\/\/doi.org\/10.4103\/1008-682x.122868","relation":{},"ISSN":["1008-682X"],"issn-type":[{"value":"1008-682X","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}